AU2023240729A1 - Aqueous composition - Google Patents

Aqueous composition Download PDF

Info

Publication number
AU2023240729A1
AU2023240729A1 AU2023240729A AU2023240729A AU2023240729A1 AU 2023240729 A1 AU2023240729 A1 AU 2023240729A1 AU 2023240729 A AU2023240729 A AU 2023240729A AU 2023240729 A AU2023240729 A AU 2023240729A AU 2023240729 A1 AU2023240729 A1 AU 2023240729A1
Authority
AU
Australia
Prior art keywords
aqueous composition
present
salts
sodium
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023240729A
Other languages
English (en)
Inventor
Chise KITANI
Akinori Nishimoto
Rika ORITANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsubota Laboratory Inc
Original Assignee
Tsubota Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Laboratory Inc filed Critical Tsubota Laboratory Inc
Publication of AU2023240729A1 publication Critical patent/AU2023240729A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2023240729A 2022-03-25 2023-03-24 Aqueous composition Pending AU2023240729A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25
JP2022-050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
AU2023240729A1 true AU2023240729A1 (en) 2024-10-03

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023240729A Pending AU2023240729A1 (en) 2022-03-25 2023-03-24 Aqueous composition

Country Status (14)

Country Link
US (1) US20250213510A1 (https=)
EP (1) EP4483867A1 (https=)
JP (1) JPWO2023182480A1 (https=)
KR (1) KR20240159636A (https=)
CN (1) CN118973561A (https=)
AU (1) AU2023240729A1 (https=)
CA (1) CA3254664A1 (https=)
CL (1) CL2024002831A1 (https=)
IL (1) IL315871A (https=)
MA (1) MA67594B1 (https=)
MX (1) MX2024011634A (https=)
PE (1) PE20250746A1 (https=)
TW (1) TW202400133A (https=)
WO (1) WO2023182480A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2018181294A1 (ja) * 2017-03-27 2018-10-04 興和株式会社 医薬製剤
JP7474706B2 (ja) 2018-12-18 2024-04-25 参天製薬株式会社 4-フェニル酪酸を含有する老視の治療または予防剤

Also Published As

Publication number Publication date
TW202400133A (zh) 2024-01-01
US20250213510A1 (en) 2025-07-03
CN118973561A (zh) 2024-11-15
IL315871A (en) 2024-11-01
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13
MA67594A1 (fr) 2025-07-31
CL2024002831A1 (es) 2025-01-24
JPWO2023182480A1 (https=) 2023-09-28
MA67594B1 (fr) 2026-01-30
WO2023182480A1 (ja) 2023-09-28
EP4483867A1 (en) 2025-01-01
KR20240159636A (ko) 2024-11-05
MX2024011634A (es) 2024-09-30

Similar Documents

Publication Publication Date Title
ES2238574T3 (es) Formulaciones de olopatadina para administracion topica.
AU2002310461A1 (en) Olopatadine formulations for topical administation
KR20180052130A (ko) 리포산 콜린 에스테르 조성물, 및 생체적합성 안과용 제형의 생성 방법
JP2021130657A (ja) 医薬製品
JP2025142313A (ja) ソフトコンタクトレンズ用眼科組成物
AU2023240729A1 (en) Aqueous composition
US20220125801A1 (en) Ophthalmic composition of bimatoprost
JP2003190249A (ja) 洗眼用具
ES2337501T3 (es) Preparacion oftalmica que comprende goma de xantano y terpenoide.
JP2025011339A (ja) 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
JP2021130628A (ja) 医薬製品
JPWO2014119643A1 (ja) 澄明な水性液剤
HK40113837A (zh) 水性组合物
AU2024347518A1 (en) Aqueous composition
TW202444342A (zh) 水性組成物
EP4534081A1 (en) Ophthalmic composition
EP4512404A1 (en) Composition for ophthalmic use containing sepetaprost
EP4534082A1 (en) Ophthalmic composition
JP2025004896A (ja) 眼科組成物
WO2024010044A1 (ja) 眼科組成物
HK40004290A (en) Atropine-containing aqueous composition
JP2010090119A (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤